Pancragen

Pancragen is a lyophilized peptide complex composed of short-chain amino acid sequences, presented in a 10 mg vial for laboratory research use. Each vial is tested for purity, endotoxins, and heavy metals, reflecting the quality standards expected from a precision research reagent.

Research background

Pancragen has been investigated in scientific settings for its interactions with pancreatic tissue signalling and tissue-specific cellular regulatory processes. The compound has been studied in experimental models exploring metabolic regulation, cellular communication, and pancreatic signalling pathways. Research interest centres on its potential role in modulating the biochemical processes associated with pancreatic function and broader metabolic homeostasis.

• Peptide complex composed of short-chain amino acid sequences
• Studied in relation to pancreatic tissue signalling and cellular regulatory mechanisms
• Investigated within experimental models relevant to metabolic regulation and cellular communication
• Applied in research contexts involving pancreatic and metabolic pathways

Reconstitution & handling

Pancragen is supplied as a lyophilized powder and should be reconstituted with an appropriate volume of bacteriostatic water (BAC water) prior to use. Add the BAC water slowly to the vial and gently swirl to dissolve — do not shake, as this may compromise peptide integrity. Handle under aseptic conditions throughout.

Storage & stability

The lyophilized product should be stored in a cool, dry environment, protected from light and moisture. For longer-term storage, freezing is recommended. Once reconstituted, the solution should be kept refrigerated and used within a short timeframe to preserve compound integrity.

A batch-specific Certificate of Analysis (CoA) accompanies every order, documenting purity, endotoxin, and heavy metal testing results for the supplied material.